NetraMark Holdings, Inc. engages in the development of artificial intelligence and machine learning solutions. The company is headquartered in Toronto, Ontario. The company went IPO on 2021-06-08. The Company’s product offering uses a novel topology-based algorithm that has the ability to parse patient data sets into subsets of people that are strongly related according to several variables simultaneously. This allows the Company to use a variety of ML methods, depending on the character and size of the data, to transform the data into powerfully intelligent data that activates traditional AI/ML methods. The result is that it can work with smaller datasets and accurately segment diseases into different types, as well as accurately classify patients for sensitivity to drugs and/or efficacy of treatment. The typical molecular data used is RNASeq, microarray, single nucleotide polymorphism (SNP) and methylation.
Follow-Up Questions
NetraMark Holdings Inc 'in CEO'su kimdir?
Mr. George Achilleos 2021 'den beri şirketle birlikte olan NetraMark Holdings Inc 'in President 'ıdır.
AINMF hissesinin fiyat performansı nasıl?
AINMF 'in mevcut fiyatı $0.8636 'dir, son işlem günde 0% decreased etti.
NetraMark Holdings Inc için ana iş temaları veya sektörler nelerdir?
NetraMark Holdings Inc Health Care endüstrisine ait ve sektör Health Care 'dir